TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
IQV

IQVIA Holdings Inc

Healthcare · Diagnostics & Research

269.40$ +0.2% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios IQV
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Valuation
21.7 22.3 100.6 16.6 93.4 161.5 125.2 56.9 35.8 31.7 26.2 28.8
1.4 1.5 1.7 2.2 2.3 2.8 3.1 4.0 2.7 2.9 2.3 2.4
1.3 2.7 3.6 5.1 5.8 9.1 6.8 7.1 5.9 6.0
1.7 1.8 2.6 3.2 3.3 3.8 4.0 4.7 3.5 3.7 3.1 3.2
12.7 13.2 20.7 18.8 18.2 20.8 22.0 23.8 17.4 17.0 14.0 15.3
22.1 21.7 16.6 36.3 30.4 36.9 26.0 23.9 24.6 28.7 17.0 19.1
4.5% 4.6% 6.0% 2.8% 3.3% 2.7% 3.8% 4.2% 4.1% 3.5% 5.9% 5.2%
Margins
27.5% 28.3% 30.3% 35.1% 35.2% 34.2% 34.0% 33.5% 34.9% 35.0% 34.9% 26.3%
10.8% 11.3% 9.4% 7.4% 7.1% 7.0% 6.4% 10.0% 12.5% 13.2% 14.3% 14.0%
6.5% 6.7% 1.7% 13.5% 2.5% 1.7% 2.5% 7.0% 7.6% 9.1% 8.9% 8.3%
6.4% 6.9% 10.2% 6.2% 7.6% 7.5% 11.8% 16.6% 11.0% 10.0% 13.7% 12.6%
Returns
1.3% 16.1% 3.9% 3.2% 4.6% 16.0% 18.9% 22.2% 22.6% 20.9%
10.8% 9.9% 0.5% 5.8% 1.1% 0.8% 1.1% 3.9% 4.3% 5.1% 5.1% 4.5%
Balance Sheet & Debt
1,426 1,491 6,002 9,266 10,116 10,808 10,719 10,759 11,531 12,297 12,281 13,744
2.0 1.9 7.1 5.6 5.4 5.4 5.2 3.9 4.0 3.8 3.6 4.0
-21.3% -8.5% 40.7% 35.7% 29.8% 25.8% 24.4% 24.5% 22.8% 22.9% 22.6% 21.7%
0.8 1.3 1.6 1.9 2.1 2.0 2.2 2.2 2.3 2.4
Per Share
2.72 3.08 0.76 5.88 1.24 0.96 1.43 4.95 5.72 7.29 7.49 7.84
41.65 45.67 44.84 43.58 50.01 55.55 58.25 71.15 75.60 80.43 84.00 94.01
-5.37 -2.67 56.80 36.43 32.25 30.08 30.77 30.98 30.25 32.81 33.08 37.48
2.66 3.16 4.58 2.70 3.82 4.18 6.89 11.81 8.32 8.05 11.53 11.82

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?